NORMAL SITUATION

Les Pharmacies du Louvy

Export PDF

Company — Normal situation.

Financial year 2024 · Closed on 31/12/2024

Net result43,3 k €+344,5 %over 1 year
Gross margin52,3 k €+404,9 %over 1 year
Equity110,2 k €+64,6 %over 1 year

Identity

Source · BCE/KBO

Les Pharmacies du Louvy is a company registered in Belgium.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0419.903.102
Legal form
Private limited company
Contributed capital
18 592,00 €
Latest accounts
31/12/2024
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 45 filings

Trend over 19 financial years

20242023202220212020
Income statement
Gross margin52,3 k €-17,2 k €8 k €24,3 k €24,3 k €
EBITDA51,9 k €-17,5 k €7,6 k €23,9 k €24 k €
Operating result51,9 k €-17,5 k €7,6 k €23,9 k €24 k €
Net result43,3 k €-17,7 k €5,6 k €17,8 k €17,8 k €
Balance sheet
Equity110,2 k €67 k €84,6 k €79,1 k €161,2 k €
Total assets110,2 k €67,3 k €84,6 k €180,5 k €163,1 k €
Cash109,4 k €58,1 k €79,4 k €180,4 k €17,9 k €
Debts22 €385 €–101,4 k €1,9 k €

Board of directors

Source · NBB, accounts to 31/12/2024

1 active · 4 ended

Active mandates

GESTIPHARMA

Director · since 25 novembre 2022 · 0425.530.684

Represented by PIERRE PASCAL HECQ

Active

Ended mandates

PIERRE PASCAL HECQ

Director · since 25 novembre 2022

Ended
PIERRE PASCAL HECQ

Director · since 07 avril 2009

Ended
PIERRE PASCAL HECQ

Manager · since 07 avril 2009

Ended
PIERRE PASCAL HECQ

Manager · since 07 avril 2003 · until 07 avril 2009

Ended

Full financial information

Source · NBB
202420232022202120202019
Type of accountMicro modelMicro modelMicro modelMicro modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date14/07/202506/08/202423/08/202316/08/202209/08/202125/08/2020
General meeting07/06/202501/06/202403/06/202304/06/202205/06/202106/06/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 45 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202407/06/202514/07/2025FrenchPDF
Micro model31/12/202301/06/202406/08/2024FrenchPDF
Micro model31/12/202203/06/202323/08/2023FrenchPDF
Micro model31/12/202104/06/202216/08/2022FrenchPDF
Abridged model31/12/202005/06/202109/08/2021FrenchPDF
Abridged model31/12/201906/06/202025/08/2020FrenchPDF
Abridged model31/12/201801/06/201907/08/2019FrenchPDF
Abridged model31/12/201702/06/201820/07/2018FrenchPDF
Abridged model31/12/201603/06/201703/07/2017FrenchPDF
Abridged model31/12/201504/06/201619/07/2016FrenchPDF
Abridged model31/12/201406/06/201513/08/2015FrenchPDF
Abridged model31/12/201307/06/201423/07/2014FrenchPDF
Abridged model31/12/201201/06/201325/06/2013FrenchPDF
Abridged model31/12/201102/06/201219/06/2012FrenchPDF
Abridged model31/12/201004/06/201108/07/2011FrenchPDF
Abridged model31/12/200905/06/201016/06/2010FrenchPDF
Abridged model31/12/200806/06/200923/07/2009FrenchPDF
Abridged model31/12/200707/06/200823/07/2008FrenchPDF
Abridged model31/12/200602/06/200720/07/2007FrenchPDF
Abridged model31/12/200503/06/200626/06/2006FrenchPDF
Abridged model31/12/200404/06/200515/06/2005FrenchPDF
Abridged model31/12/200330/08/200431/08/2004FrenchPDF
Abridged model31/12/200207/06/200319/06/2003FrenchPDF
Abridged model31/12/200101/06/200217/06/2002FrenchPDF

View all 45 filings

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

1 active · 4 ended

Active mandates

GESTIPHARMA

Director · since 25 novembre 2022 · 0425.530.684

Represented by PIERRE PASCAL HECQ

Active

Ended mandates

PIERRE PASCAL HECQ

Director · since 25 novembre 2022

Ended
PIERRE PASCAL HECQ

Director · since 07 avril 2009

Ended
PIERRE PASCAL HECQ

Manager · since 07 avril 2009

Ended
PIERRE PASCAL HECQ

Manager · since 07 avril 2003 · until 07 avril 2009

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Dissolution19/01/2026
    RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
    PDF
  • Other04/01/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE - DIVERS
    PDF
  • Other27/12/2013
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates29/07/2011
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 202443,3 k €↑
  2. 2023
    Annual accounts 2023-17,7 k €↓
  3. 2022
    Annual accounts 20225,6 k €↓
  4. 2021
    Annual accounts 202117,8 k €↑
  5. 2020
    Annual accounts 202017,8 k €↑
  6. 2019
    Annual accounts 201915,7 k €↓
  7. 2018
    Annual accounts 201815,9 k €↓
  8. 2017
    Annual accounts 201716,2 k €↑
  9. 2016
    Annual accounts 20168,2 k €↓
  10. 2015
    Annual accounts 201517,7 k €↑
  11. 2014
    Annual accounts 201417,4 k €↑
  12. 2013
    Annual accounts 201316,5 k €↓
  13. 2012
    Annual accounts 201218,3 k €↑
  14. 2011
    Annual accounts 201116,2 k €↑
  15. 2010
    Annual accounts 201015,7 k €↓
  16. 2009
    Annual accounts 200917,4 k €↑
  17. 2008
    Annual accounts 200815,5 k €↓
  18. 2007
    Annual accounts 200717,2 k €↑
  19. 2006
    Annual accounts 200613,3 k €